Ling-Di Li
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 27
- Acute Myeloid Leukemia Research 19
- Multiple Myeloma Research and Treatments 8
- Chronic Myeloid Leukemia Treatments 6
-
- Retinoids in leukemia and cellular processes 5
- Co-authors
- Xiao‐Jun Huang (23 shared papers)Ya‐Zhen Qin (12 shared papers)Jinlan Li (17 shared papers)Qun Yu (1 shared paper)Lijun Li (1 shared paper)Guo‐Rui Ruan (13 shared papers)Pin Wu (1 shared paper)Dang Wu (1 shared paper)
- Journals
- Leukemia Research (5 papers)Scientific Reports (2 papers)Journal of China Tourism Research (1 paper)Frontiers in Immunology (1 paper)Technology in Cancer Research & Treatment (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Ling-Di Li
43 papers receiving 393 citations
Peers
Comparison fields: 5 of 74
- Hematology 196
- Genetics 84
- Molecular Biology 210
- Cancer Research 41
- Immunology 55
Countries citing papers authored by Ling-Di Li
This map shows the geographic impact of Ling-Di Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling-Di Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling-Di Li more than expected).
Fields of papers citing papers by Ling-Di Li
This network shows the impact of papers produced by Ling-Di Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling-Di Li. The network helps show where Ling-Di Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling-Di Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 64 | |
| 2 | 2008 | 47 | |
| 3 | 2013 | 28 | |
| 4 | 2012 | 22 | |
| 5 | 2010 | 22 | |
| 6 | 2013 | 22 | |
| 7 | 2017 | 19 | |
| 8 | 2016 | 17 | |
| 9 | 2015 | 15 | |
| 10 | 2016 | 15 | |
| 11 | 2014 | 12 | |
| 12 | 2015 | 9 | |
| 13 | 2014 | 8 | |
| 14 | [Detection of common fusion transcript levels in untreated leukemia patients by real-time quantitative RT-PCR technique]. | 2007 | 7 |
| 15 | 2021 | 7 | |
| 16 | [Adenovirus-mediated PDCD5 gene transfer sensitizes apoptosis of K562 cells induced by etoposide]. | 2007 | 6 |
| 17 | 2020 | 6 | |
| 18 | [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia]. | 2007 | 5 |
| 19 | [Leukemia-associated immunophenotypes in 415 childhood and adult patients with B lineage acute lymphoblastic leukemia by multiparametric flow cytometry analysis]. | 2006 | 5 |
| 20 | 2014 | 5 |
About Ling-Di Li
Ling-Di Li is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Immunology, having authored 45 papers that have together received 398 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Multiple Myeloma Research and Treatments (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers), Retinoids in leukemia and cellular processes (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Immunotherapy and Immune Responses (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Hematology (196 citations), Genetics (84 citations), Molecular Biology (210 citations), Cancer Research (41 citations) and Immunology (55 citations). Ling-Di Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xiao‐Jun Huang, Ya‐Zhen Qin, Jinlan Li, Qun Yu, Lijun Li, Guo‐Rui Ruan, Pin Wu, Dang Wu, Bin Jiang and Yanrong Liu. Their work appears in journals such as Leukemia Research, Scientific Reports, Journal of China Tourism Research, Frontiers in Immunology and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.